United States · Investor

Leerink Partners

Last cheque observed Feb 2026; 8 cheques on record.

Email

Deploying nowGrowth equity

Series BSeries CSeries AFashionNutrition

Deploying now
100%of best year1cheques in 12 months, 8 on record
Since the last cheque246days00hrs00min00sec
Median round$120MRounds led0 of 8Exits1 from the portfolioMostly inUnited States, 100%
Pitch Leerink Partners

Leerink Partners highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series B and Series C: 83% of its rounds

  3. 03

    1 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
FashionNutrition
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first8 appearances

  1. 2026

    1 round

  2. Feb
    Zura BioUS · Ventureburn$144MWith 4 others
  3. 2019

    1 round

  4. May
    AlloVirSeries B · US · Crunchbase News$120MWith 9 others
  5. 2018

    1 round

  6. May
    FogPharmaSeries B · US · FinSMEs$66MWith 7 others
  7. 2017

    2 rounds

  8. Sept
    ReplimuneSeries B · US · FinSMEs$55MWith 6 others
  9. May
    Outcome HealthUS · FinSMEs$600MWith 4 others
  10. 2015

    1 round

  11. Sept
    KyruusSeries C · US$25MWith 7 others
  12. 2013

    1 round

  13. Feb
    Living ProofSeries C · US · pevc.dowjones.com$30MWith 1 other
  14. 2009

    1 round

  15. Oct
    HumedicaSeries A · US · onbiovc.com$30MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed1 in all

HumedicaBought by United HealthUndisclosedJan 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Leerink Partners. A count of rooms they were both in, not a relationship either has claimed.

Redmile GroupVC firm2rounds together

Recently backed

The latest companies Leerink Partners put money into.

Zura Bio$144M · Feb 2026AlloVir$120M · May 2019FogPharma$66M · May 2018Outcome Health$600M · May 2017

Quick answers about Leerink Partners

What does Leerink Partners invest in?

Leerink Partners invests most often at Series B and Series C (83% of the rounds on record), in sectors such as Fashion and Nutrition.

How active is Leerink Partners?

8 investments on record, 1 of them in the last 12 months. The most recent was in Feb 2026.

What has Leerink Partners invested in recently?

Its most recent investments on record: Zura Bio (Undisclosed round, Feb 2026), AlloVir (Series B, May 2019) and FogPharma (Series B, May 2018).

How big are Leerink Partners's cheques?

The median round it joins is $120M.

Does Leerink Partners lead rounds?

Rarely, if at all: none of its 8 investments on record names it as the lead.

Where does Leerink Partners invest?

Most of the companies it backs are in the United States (100%).

Is Leerink Partners investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Leerink Partners invest alongside?

Most often Redmile Group (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it